India Corporate Governance MCA ROC Filings — June 09, 2026
The June 9, 2026 corporate governance filings from 50 Indian companies reveal a market in a pronounced capital-raising cycle, with at least seven companies (Rungta Irrigation, Finkurve Financial, Mukka Proteins, Oasis Securities, Aptus Pharma, Novelix Pharmaceuticals, Porwal Auto Components) initiating rights issues, preferential allotments, or NCD placements this week. This signals a broad-based need for capital, particularly among smaller and mid-tier firms. A critical governance flashpoint has emerged at **Advance Metering Technology Limited**, where shareholders overwhelmingly defeated three major resolutions related to related-party transactions and loans, with promoter votes being declared invalid, pointing to potential control and voting irregularities. Conversely, a strong profit growth story is visible at **Goldline Pharmaceutical Ltd** (PAT +45.3% YoY) and **Elegant Floriculture** (revenue surging to ₹16,003 Lakh from ₹129 Lakh), though both face working capital strain. Negative signals are mounting at **Indus Fila Ltd**, which reported widening losses and a qualified audit opinion citing governance failures, while its listing remains suspended. Geographically, there is a cluster of M&A and restructuring activity in the infrastructure and metals space, with mergers proposed at Manbro Industries (renamed KD Green Industries) and Highway Infrastructure. The aggregate data suggests a mixed market environment: while some firms are aggressively expanding or restructuring with investor support, others are facing shareholder revolts and deteriorating fundamentals, making selective, event-driven investing critical.